Abiomed (ABMD) Halted Ahead of FDA Meeting on Blood Pumps
- Top 10 News for 9/15 - 9/19: Markets Welcome Alibaba IPO; New iPhone Sets Records; Fed Remains Accommodative
- Alibaba (BABA) IPO Lights Up Wall Street
- Stock Futures Higher as Scotland Votes Down Independence, Alibaba's (BABA) IPO Prices
- Telefónica S.A. (TEF), Vivendi (VIVHY) Agree to $9.3B Deal for Global Village Telecom
- Are Yahoo! (YHOO) Investors Ready to 'Sell the News'? Analyst Weighs In
Abiomed, Inc. (NASDAQ: ABMD) halted ahead of FDA advisory committee meeting over nonroller-type cardiopulmonary bypass blood pumps.
You May Also Be Interested In
- Abiomed (ABMD) Updates on RECOVER RIGHT Clinical Trial Results
- Endo (ENDP) Makes $28.10/Share Bid for Auxilium Pharma (AUXL)
- Nektar Therapeutics (NKTR) Wins FDA Approval of Movanik
Create E-mail Alert Related CategoriesFDA, Trading Halts
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!